Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

Mustafa Karaca; Mustafa Serkan Alemdar; Özge Deniz Karaca; Yıldız Kılar; Gökhan Köker; Hasan Sözel; Mustafa Yıldız; Gülhan Özçelik Köker; Mustafa Özgür Arici

doi:10.12659/MSM.945240

26 November 2024 : Clinical Research

Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

Mustafa Karaca^1ACDEF, Mustafa Serkan Alemdar^2BDF, Özge Deniz Karaca^3ABEF, Yıldız Kılar^4BD, Gökhan Köker^3BEF, Hasan Sözel^5CDE, Mustafa Yıldız^2DEF, Gülhan Özçelik Köker^1DEF, Mustafa Özgür Arici

^2BDEF*

DOI: 10.12659/MSM.945240

Med Sci Monit 2024; 30:e945240

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Kaplan-Meier survival curve for disease-free survival according to sarcopenia change status. No statistical difference was found between patients with pre-NAC sarcopenia and post-NAC sarcopenia. We used the SPSS 29.0 software package (IBM Corp., Armonk, NY) to draw this figure. NAC – neoadjuvant chemotherapy.

Back to the Article

Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis

Your Privacy